{"address1": "1025 Connecticut Avenue NW", "address2": "Suite 1000", "city": "Washington", "state": "DC", "zip": "20036", "country": "United States", "phone": "202 327 5422", "website": "https://www.60degreespharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Geoffrey Stuart Dow Ph.D.", "age": 50, "title": "Chairman, CEO & President", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 248000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyrone  Miller", "age": 49, "title": "CFO & Treasurer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 224000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Landon", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 413570, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bryan  Smith", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.8, "open": 1.7903, "dayLow": 1.7771, "dayHigh": 1.915, "regularMarketPreviousClose": 1.8, "regularMarketOpen": 1.7903, "regularMarketDayLow": 1.7771, "regularMarketDayHigh": 1.915, "payoutRatio": 0.0, "forwardPE": -1.0617977, "volume": 11641, "regularMarketVolume": 11641, "averageVolume": 466895, "averageVolume10days": 27040, "averageDailyVolume10Day": 27040, "bid": 1.33, "ask": 2.35, "bidSize": 2, "askSize": 1, "marketCap": 2783800, "fiftyTwoWeekLow": 1.41, "fiftyTwoWeekHigh": 36.0, "priceToSalesTrailing12Months": 4.085742, "fiftyDayAverage": 2.5385, "twoHundredDayAverage": 6.55225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9038675, "profitMargins": 0.0, "floatShares": 1282859, "sharesOutstanding": 1472910, "sharesShort": 51389, "sharesShortPriorMonth": 23788, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0349, "heldPercentInsiders": 0.043330003, "heldPercentInstitutions": 0.02088, "shortRatio": 0.66, "shortPercentOfFloat": 0.0354, "impliedSharesOutstanding": 1472910, "bookValue": -9.758, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -8430408, "trailingEps": -18.55, "forwardEps": -1.78, "lastSplitFactor": "1:5", "lastSplitDate": 1740355200, "enterpriseToRevenue": 13.266, "enterpriseToEbitda": -0.935, "52WeekChange": -0.8866906, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.89, "targetHighPrice": 17.0, "targetLowPrice": 17.0, "targetMeanPrice": 17.0, "targetMedianPrice": 17.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 3387825, "totalCashPerShare": 2.3, "ebitda": -9664703, "totalDebt": 155891, "quickRatio": 2.338, "currentRatio": 3.25, "totalRevenue": 681345, "debtToEquity": 3.942, "revenuePerShare": 1.499, "returnOnAssets": -0.89667, "returnOnEquity": -1.81779, "grossProfits": -2930720, "freeCashflow": -648401, "operatingCashflow": -5648088, "revenueGrowth": 5.122, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -7.93999, "financialCurrency": "USD", "symbol": "SXTP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "preMarketTime": 1743597413, "regularMarketTime": 1743537600, "marketState": "PRE", "regularMarketChangePercent": 5.000002, "regularMarketPrice": 1.89, "shortName": "60 Degrees Pharmaceuticals, Inc", "longName": "60 Degrees Pharmaceuticals, Inc.", "exchange": "NCM", "messageBoardId": "finmb_241910140", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketChange": 0.04000008, "preMarketChangePercent": 2.2099493, "preMarketPrice": 1.85, "regularMarketChange": 0.09000003, "regularMarketDayRange": "1.7771 - 1.915", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 466895, "fiftyTwoWeekLowChange": 0.48000002, "fiftyTwoWeekLowChangePercent": 0.34042555, "fiftyTwoWeekRange": "1.41 - 36.0", "fiftyTwoWeekHighChange": -34.11, "fiftyTwoWeekHighChangePercent": -0.9475, "fiftyTwoWeekChangePercent": -88.66906, "epsTrailingTwelveMonths": -18.55, "epsForward": -1.78, "epsCurrentYear": -13.55, "priceEpsCurrentYear": -0.13948339, "fiftyDayAverageChange": -0.6485001, "fiftyDayAverageChangePercent": -0.25546587, "twoHundredDayAverageChange": -4.66225, "twoHundredDayAverageChangePercent": -0.71154946, "priceToBook": -0.19368722, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-07-12", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1689168600000, "displayName": "60 Degrees Pharmaceuticals", "trailingPegRatio": null}